Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?Mariëtte E.G. Kranendonk, Sabine Plasschaert, Nelleke Tolboom et al.|Neuro-Oncology|2025Cited by 6
BIOM-03. Gut microbiome α-diversity is associated with overall survival in pediatric embryonal tumors and high-grade gliomasRaoull Hoogendijk, Jasper van der Lugt, Mariëtte E.G. Kranendonk et al.|Neuro-Oncology Pediatrics|2025Cited by 0